Podcasts about Wilms

"Certamen Rheno-Palatinum": Das ist ein Wettbewerb für Gymnasiasten, die richtig gut sind in Latein und Altgriechisch. Die Mehrheit der Schülerinnen und Schüler lernen diese Sprachen aber nicht mehr. Weil vor allem die ausgestorbene Sprache Latein als elitär und aus der Zeit gefallen gilt? "Das ist eine Vorstellung, die sich durch die Praxis überholt hat", sagt Hartmut Wilms, Lateinlehrer und Organisator des Landeswettbewerbs Alte Sprachen in Rheinland-Pfalz. "Die teilnehmenden Schülerinnen und Schüler kommen aus nahezu jeder sozialen Schicht, und wir haben auch immer eine gute Anzahl an Migrantinnen und Migranten dabei". Im Gespräch mit SWR Aktuell-Moderatorin Ulrike Alex erklärt Wilms, warum besonders letztere von Latein deutlich profitieren können. Und wie Latein-Kenntnisse uns allen helfen, wenn wir in einer anderen Fremdsprache mal improvisieren müssen.

2025 - 04 - 27 - Martin Mobach - Repentance and the Good News of the Kingdom (read by Jared Wilms) by FHCRC Podcast

This episode covers Wilms' tumour.Written notes can be found at https://zerotofinals.com/paediatrics/renal/wilmstumour/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

Valerie Wilms war jahrelang Bundestagsabgeordnete der Grünen – und ist heute eine der schärfsten Kritikerinnen der Partei. In ihrem Buch „Meine zwei Leben – Als Frau im Bundestag, als Junge geboren“ schildert sie eindrucksvoll ihre persönliche und politische Geschichte. Im Gespräch mit Maximilian Tichy spricht Wilms über ihre Transition in den 1990er-Jahren, lange bevor das Thema Transsexualität in der Öffentlichkeit thematisiert wurde. Anders als heutige Identitätspolitiker stellte sie ihre persönliche Geschichte nie in den Vordergrund, sondern arbeitete konsequent an sachpolitischen Themen wie Verkehr und europäischer Finanzpolitik. Im Interview erklärt sie, warum sie sich aufgrund der Genderpolitik von den Grünen distanziert hat, wie sie den wachsenden Einfluss der Woke-Bewegung auf die politische Debatte sieht und weshalb sie für eine klare Trennung zwischen biologischem Geschlecht und ideologischer Geschlechtsidentität plädiert. Wilms gibt einen seltenen Einblick in ihre innere Auseinandersetzung während der Griechenlandkrise, schildert ihren Gewissenskonflikt bei Abstimmungen und kritisiert die mangelnde Offenheit für fraktionsübergreifende Lösungen im Bundestag. Ein aufrichtiges Gespräch über politische Unabhängigkeit, Identität und Integrität – und ein eindrucksvolles Zeugnis einer Frau, die nicht bereit war sich einer Partei zu beugen.

While rubbing her 3 year old daughter Chelsea's belly, Alison Hicks felt a lump which was shortly diagnosed as a Stage 4 Wilms Tumor. Chelsea fought this Pediatric  Kidney Cancer for nearly 2 years before passing away after a treatment protocol which was very difficult from the beginning to its end. As a result of Chelsea's battle and passing, Alison started the Chelsea Hicks Foundation which focuses on keeping a smile on Pediatric Cancer patients as they go through their impatient hospital treatments. 

Plots ben je leider. Je gooit je volop in die nieuwe uitdaging en je loopt - onvermijdelijk -  tegen onvoorziene opstakels aan. Je trapt in klassieke valkuilen en soms loopt dat niet goed af… Bij Steve Vandenberghe, burgermeester van Bredene en Vlaams volksvertegenwoordiger leidde dat in 2021 tot een zware burn-out. Samen met Brigitte Ballings, door het ICF erkend leiderschaps- en veerkrachtcoach, schreef hij het boek ‘Gegijzeld door jezelf'. Brigitte hielp hem terug rechtkrabbelen zodat hij weer in zijn kracht kon komen te staan. Ik heb het boek gelezen. Het is een aanrader voor wie zichzelf nooit (of nooit meer) wil laten gijzelen. En naar aanleiding daarvan heb ik hen beiden uitgenodigd voor een schaamteloos bezoek in hun hoofd. En ze zijn daarvoor helemaal afgezakt naar de Kempen, want dat is waar we deze keer onze podcast corner hebben opgeslagen. Bij de schaduwmeesters van WilmsVeel kijk- en luisterplezier! +++Honger naar meer? SCHRIJF JE IN VOOR DE NIEUWSBRIEF LEES DE ARTIKELSABONNEER JE OP HET BOOKAZINEAnd don't forget: it's a great time to be in HR!+++Opgenomen bij Wilms

Ik ben deze keer afgezakt naar de Kempen want ik ben vandaag te gast bij het Wilms Experience Center, de prachtige showroom gelegen aan de Molsebaan in Meerhout. Een familiebedrijf deze keer. CEO Erik Wilms is sinds 2010 als tweede generatie aan het roer. Meer dan 200 schaduwmeesters werken hier en die krijgen onwaarschijnlijk veel kansen om te groeien. Dat heeft Tina Ermgodts mij verteld. Ze is HR en duurzaamheidsmanager bij Wilms. Ze gaan hier op zoek naar het talent van elke medewerker en zetten in op langetermijnrelaties met hun mensen. Hoe dat concreet vorm krijgt in de praktijk, ontdek je in deze aflevering. Veel kijk- en luisterplezier!+++Honger naar meer? SCHRIJF JE IN VOOR DE NIEUWSBRIEF BLIJF OP DE HOOGTE VAN ALLE HR-ACTUA ABONNEER JE OP HET #ZIGZAGHR BOOKAZINEIt's a great time to be in HR!+++Opgenomen bij het Wilms Experience Center

Orqa Health is a meal plan delivery service in West Palm Beach, Florida that specializes in sourcing their ingredients from regenerative farms, supporting sustainable agriculture practices that enhance soil health and biodiversity.Orqa Health:Website: https://www.orqahealth.com/Instagram: https://www.instagram.com/orqahealth/Facebook: https://www.facebook.com/orqahealth/ Dr Steph's Links: Tiktok: https://www.tiktok.com/@drstephpeacockInstgram: https://www.instagram.com/drstephpeacock/ Sunlighten: https://www.facebook.com/HealthyGutCompany/ code: DRPEACOCK Airdoctor: https://stephaniepeacock.com/affiliate-airdoctor AquaTru: https://stephaniepeacock.com/affiliate-aquatru Prolon: https://stephaniepeacock.com/affiliate-prolon Work with me: https://stephaniepeacock.com/ Subscribe to my newsletter: https://stephanies-newsletter-c410d1.beehiiv.com/subscribe

Welcome to the Sterile Technique Podcast! It's the podcast about Surgical Technology. Whether you are a CST or CSFA, this podcast helps you earn CE credits and improve your surgery skills in the OR. This episode discusses an article in the February 2025 issue of The Surgical Technologist, the official journal of the Association of Surgical Technologists (AST). The article is titled, "Nephron-Sparing Surgery for Wilms Tumor". "Scrub in" at steriletpodcast.com and on Twitter, @SterileTPodcast (twitter.com/SterileTPodcast). This podcast is a Dybas Media production. Sound effects adapted from GarageBand and sindhu.tms at https://freesound.org/people/sindhu.tms/sounds/169065/ and licensed courtesy of https://creativecommons.org/licenses/by-nc/3.0/.

Een nieuwe maand, dat betekent ook een nieuwe #ZigZagHR Actua Podcast. Ook deze maand duik ik in de arbeidsmarkt om in te zoomen op cijfers, onderzoek en topics waar jij als HR-professional ongetwijfeld mee bezig bent. Vergrijzing versnelt, arbeidsmigratie neemt toe, levensverwachting stijgt: uitdagingen voor HR23 van de 51 duurzaamheidsindicatoren evolueren ongunstig: welzijn België bereikt dieptepuntWerkgelegenheid stagneert, werkloosheid stijgt, beperkte loongroei en daling loonsubsidies1 op 5 voelt zich gevangen in een gouden kooi (onderzoek Tempo Team) + trampolinepremieEr zijn vandaag 251 prioritaire knelpuntberoepenBoek van de maand 'Breek uit de gouden kooi' (Bernard Moerman)Sine Labore Nihil (Bart De Wever)Veel kijk- en luisterplezier!+++Honger naar meer? SCHRIJF JE IN VOOR DE NIEUWSBRIEFBLIJF OP DE HOOGTE VAN ALLE HR-ACTUA ABONNEER JE OP HET #ZIGZAGHR BOOKAZINE It's a great time to be in HR!+++Opgenomen bij Wilms met dank aan Tina Ermgodts

✅Está no ar mais um UroCast ABC!

Lo Que Nos Cuenta El Cuento - Quién Eres, Teresa Wilms Montt by Radiotelevisión de Veracruz

Megan Nelson's mom felt an odd lump as she was hugging her 2 year old granddaughter Ella before returning home after Megan had given birth to her son Francis in 2020. Upon hearing this, Megan took Ella to her pediatrician and shortly thereafter she was diagnosed with the Kidney Cancer Wilms Tumor before this diagnosis was changed 3 days later to Stage 4 High Risk Neuroblastoma. Megan and her family were living in Virginia at the time but moved to Los Angeles so Ella could get her treatment at the Children's Hospital of Los Angeles. Now 4 years later, Ella is doing well and is living her best life possible. 

Wat was ze goed en wat maakte ze een indruk: Lotte Wilms liep afgelopen weekend naar een achtste plaats bij het WK Ironman in Nice. Niet alleen die fenomenale prestatie bespreken we, want ook het uitvallen van Els Visser en Diede Diederiks, natuurlijk de ontketende Laura Philipp en ook de teleurstelling van een niet van start gaande Lucy Charles-Barclay en uitgestapte Anne Haug. En: is het parcours in Nice niet een beetje te specialistisch, waardoor de spanning iets te vroeg uit de wedstrijd verdwijnt?

Event Objectives:Apply the learned epidemiology and clinical presentation of Wilms Tumor to appropriate surveillance and/or diagnostic evaluation for children at known risk due to underlying genetic syndromes or with presentation of signs and symptoms consistent this diagnosis.Contextualize the current standard of care therapies for patients with Wilms Tumor with the history of discovery and first treatments and recognize the evolution of risk stratification as the backbone of clinical trial development in Wilms Tumor.Appraise the presented supporting data on prognostic features of outcomes for patients with Wilms Tumor and evaluate the incorporation of this information into the upcoming Children's Oncology Group therapeutic protocol for the Risk Stratified Treatment of patients with Stage I- IV Favorable Histology Wilms Tumor.Discuss the presented interrelationship between organogenesis and tumorigenesis and spur innovative thought into the underlying biology of the spectrum of Wilms Tumor and nephroblastomatosis.Claim CME Credit Here!

When Lauren Bujnicki's 2 year old daughter Madison had some symptoms that needed to be checked out, the thought was that she might have a Urinary Tract Infection. Everything seemed okay except for a urinalysis that was off, but just a few days later Madison developed a low grade fever, was irritable, and vomited. Madison's diagnosis turned out to be the Kidney Cancer Stage 4 Wilms Tumor. This diagnosis was given in February of 2022 and for the next 8 months, Madison went through an arduous treatment protocol. By October of 2022, Madison did not have any Evidence of Disease and , now 2 years later as a 4 year old, Madison is doing as well as possible. 

Der gebürtige Schwanenberger Bernd Wilms erzählt von einem Geschichtsprojekt, das er vor fast 25 Jahren gemeinsam mit Dieter Nessler begonnen hat. Sie besuchten und interviewten ältere Mitbürger, die etwas über frühere Zeiten in Schwanenberg und Umgebung berichten konnten. Dabei ging es vor allem um die zahlreichen Handwerksbetriebe und Geschäfte, die es früher in Schwanenberg gegeben hat. Bernd schildert, wie es zu dem Projekt kam und was daraus wurde, dazu hören wir zum ersten Mal auch einige O-Töne aus den damals per Minidisc-Recorder aufgezeichneten Interviews. Es moderieren Lena Wilms und Robin Banerjee.

What is Nature, and what is Nurture? It's an old question that poses what is perhaps a false dichotomy. Considering out Nature, it's as old as Chinese medicine. And nourishing ourselves so as to enjoy the full measure of our days, also has a long history of inquiry and practice. As practitioners we need to know how to take care of ourselves as part of being able to care for others. The tenets of East Asian medicine suggest that different kinds of people need different things. Sun Xi Miao is one of the leading authorities on medicine and cultivation. In this conversation with Sabine Wilms and Leo Lok we discuss their perspective on what Sun Si Miao has passed down to us, and a special program they are offering for those who want to take a deep dive into the essence of “nourishing our nature.”

Emelie Brosnihan, 7, bilateral Wilms tumor, Natick, with Kate (mom), Dave (dad)·       During the summer in 2022, Emelie was swimming with her siblings, Olivia and Liam. When they came inside for lunch, Emelie screamed and cried from pain. Her family took her to the local emergency room where it was confirmed she had masses on her kidneys. The family went to Boston where Emelie was diagnosed with Bilateral Wilms Tumors, a form of kidney cancer. Within 24 hours, Emelie had a port put in and began her first round of chemotherapy.·       Starting August 2022, Emelie underwent 12 weeks of chemotherapy to shrink the tumors on her kidneys, leaving her with half of her right kidney and two-thirds of her left. Emelie's last round of chemotherapy was in February 2023. She visited the Jimmy Fund Clinic on a monthly basis for blood work, and prescription renewal until end of May 2023, when she graduated to quarterly visits and scans.·       Emelie enjoys swimming, playing with her brother and sister, and all kinds of crafts. This past summer, Emelie was a patient partner with Homegoods and HomeSense and designed artwork for their annual bag campaign to raise money for the Jimmy Fund and Dana-Farber. Her bag designs included an underwater scene with fish and turtles, and a panda bear eating a watermelon. Emelie is going to enter second grade in the fall.

In this hour you will hear from Mason Marc-Aurele, 5, acute lymphoblastic leukemia, Windham, NH, with Ariel (mom) and Michael (dad) Leilani Hood, 1, neuroblastoma, Boston, with Liz (mom) and Chris (dad) Emelie Brosnihan, 7, bilateral Wilms tumor, Natick, with Kate (mom), Dave (dad) New England Revolution Head Coach Caleb Porter

Join us at our first in-person conference on June 25 all about AI Quality: https://www.aiqualityconference.com/. Benjamin Wilms is a developer and software architect at heart, with 20 years of experience. He fell in love with chaos engineering. Benjamin now spreads his enthusiasm and new knowledge as a speaker and author – especially in the field of chaos and resilience engineering. Retrieval Augmented Generation // MLOps podcast #237 with Benjamin Wilms, CEO & Co-Founder of Steadybit. Huge thank you to Amazon Web Services for sponsoring this episode. AWS - https://aws.amazon.com/ // Abstract How to build reliable systems under unpredictable conditions with Chaos Engineering. // Bio Benjamin has over 20 years of experience as a developer and software architect. He fell in love with chaos engineering 7 years ago and shares his knowledge as a speaker and author. In October 2019, he founded the startup Steadybit with two friends, focusing on developers and teams embracing chaos engineering. He relaxes by mountain biking when he's not knee-deep in complex and distributed code. // MLOps Jobs board https://mlops.pallet.xyz/jobs // MLOps Swag/Merch https://mlops-community.myshopify.com/ // Related Links Website: https://steadybit.com/ --------------- ✌️Connect With Us ✌️ ------------- Join our slack community: https://go.mlops.community/slack Follow us on Twitter: @mlopscommunity Sign up for the next meetup: https://go.mlops.community/register Catch all episodes, blogs, newsletters, and more: https://mlops.community/ Connect with Demetrios on LinkedIn: https://www.linkedin.com/in/dpbrinkm/ Connect with Benjamin on LinkedIn: https://www.linkedin.com/in/benjamin-wilms/ Timestamps: [00:00] Benjamin's preferred coffee [00:28] Takeaways [02:10] Please like, share, leave a review, and subscribe to our MLOps channels! [02:53] Chaos Engineering tldr [06:13] Complex Systems for smaller Startups [07:21] Chaos Engineering benefits [10:39] Data Chaos Engineering trend [15:29] Chaos Engineering vs ML Resilience [17:57 - 17:58] AWS Trainium and AWS Infecentia Ad [19:00] Chaos engineering tests system vulnerabilities and solutions [23:24] Data distribution issues across different time zones [27:07] Expertise is essential in fixing systems [31:01] Chaos engineering integrated into machine learning systems [32:25] Pre-CI/CD steps and automating experiments for deployments [36:53] Chaos engineering emphasizes tool over value [38:58] Strong integration into observability tools for repeatable experiments [45:30] Invaluable insights on chaos engineering [46:42] Wrap up

Grab you tissues friends...Although this episode is a tough one to talk about, it's an important one. Pediatric cancer is a parent's biggest fear. Getting a diagnosis like that can feel like your world is caving in, and our guests on this episode, Griffin and Britt Coxe, know that feeling all too well. Their daughter Perry (such a cute name by the way) was diagnosed with a Wilms tumor on her right kidney when she was almost 5 years old. Thankfully, Perry made it through 49 weeks of chemo and radiation to help her beat cancer, but we know not every family's story ends this way. Through their cancer journey, Griffin and Britt started the High Hopes non-profit that helps other families in need while going through cancer treatment. They even helped pay for a child's funeral which is of course something no one wants to do, but that is what the family needed. Please find it in your hearts to share their story and foundation so others in need can be helped. You can visit their website at: highhopesnonprofit.com and on Instagram and Facebook @HighHopesNonProfit

This week we are thrilled to welcome pro long course athlete Lotte Wilms to the show! Lotte has been on the rise in the long course ranks in recent years, but prior to that she competed as an Olympic swimmer and then as a short course triathlete chasing more Olympic dreams. She just fell short of that, ending up as the reserve athlete for the Dutch team, and since then, she has been killing it on the long course scene. In this episode we dive into what her journey has been like to reach the level she is at now, as well as her opinion on various topics in triathlon including drafting and race dynamics!Lotte's Instagram: @lotte_wilmsFollow us on Instagram:@feistytriathlon Feisty Media Website:https://livefeisty.com/ Support Our Partners: buycycle: Save up to $100 on your purchase by entering code FEISTYTRI at checkout at buycycle.com Orca: Use code IRONWOMEN15 for 15% off at www.orca.com The Amino Co: Shop Feisty's Favorite 100% Science-Backed Amino Acid Supplements. Enter code IRONWOMEN at Aminoco.com/IRONWOMEN to Save 30% + receive a FREE gift for new purchasers! Precision Fuel & Hydration: Use this link to get 15% off your first order - https://visit.pfandh.com/feisty-tri-pod TRIHARD: Use code 20FEISTY for 20% off sitewide at https://www.trihard.co/ This podcast uses the following third-party services for analysis: Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Chartable - https://chartable.com/privacy

On our fourth of eleven consecutive days of Spinal Tap Moments, multi-talented musician J. Wilms tells us about going to Nigeria to perform the music of hometown legend Fela Kuti with Fela's son Femi. However, Femi wasn't exactly on the same page as the rest of the band. Hear J. Wilms' album, The Fighter: https://www.jeremywilms.com -------------------------------------------------- Get in touch with Too Much Effing Perspective Contact us: hello@tmepshow.com Website: https://tmepshow.com Social: @tmepshow Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode, I am joined by Carrie Valentin. We discuss her experience with finding out that her young daughter had a form of cancer, called Wilms, that spread from her kidney to her lungs. Thankfully, Sybil is currently in remission. We discuss the trauma that cancer caused in both her life and the ripple effect it had on her family. We discuss her decision to divorce her husband and how they made a conscious effort for it to end up being a positive for their family. We also talk about Carrie's drinking and how she wouldn't label it alcoholism but that it did become a coping mechanism for her during the hard times. She is currently working on sobriety and working through both the trauma of thinking that she was going to lose her daughter as well as trauma carried forward from childhood. Carrie Anne Valentin (@carrie_be.wellness) • Instagram photos and videosDonate: Small acts solve big challenges (bcchildrens.ca)We also mention Christiana Cioffi in this episode. To check out more about her dating application or to order her book: Book | An Unapologetic SpinsterAshley (@filledupcup_) • Instagram photos and videosFilled Up Cup - Unconventional Self Care for Modern Women

When Vara James was 9 years old in 2016 she was diagnosed with the Kidney Cancer Wilms Tumor. Now 17 years old, Vara has been cancer free since February of 2018 and has many options to look at as she is able to live as normal of a life as possible. Vara and her mother Emily Gordon will talk about these past 8 years which include helping to start the Rock Cancer program along with Neuro Oncologist Dr. Carl Koschmann,  which gives Pediatric Cancer patients the opportunity to gain confidence and a sense of accomplishment by learning to Rock Climb. 

Today's guest makes me want more names. It's Jeremy Wilms and we'll go through all his different names throughout this episode. But each one has a reason. Jeremy is his family's musical version of “3rd time's a charm”. He's managed to study and play guitar with some amazing people. After college, he moved from Duluth, GA to NYC and kept studying in the form of open jam sessions with his neighbors and some naked people.  Jeremy is a guitar player but started getting actual work after he picked up the bass. That led him to playing with the legendary Chico Hamilton and Antibalas. His time in Antibalas opened more doors for him; like the time the band literally split in two when one half played live shows and the other half (Jeremy's half) eventually played on Broadway in the show based on the life of Fela Kuti. THAT led to an unusual and slightly awkward session with Jay-Z and Beyonce that has never been released.  Jeremy also talks about being in a wedding band with Elvis Costello and tells the story of Ornette Coleman's leftover Burger King. These are perfect examples of his being open to new and unusual experiences, like arranging strings for Run The Jewels, studying with Michael Mossman for a Master's in composition, and moving back to GA during COVID. That's been a big turning point in how he writes and you can really hear it in his new album, The Fighter. Definitely check that out on Bandcamp or jeremywilms.com. Follow him on Instagram @jere_wilms for album and tour info. Follow us @PerformanceAnx on X & Instagram. You can show us your love with coffee at ko-fi.com/performanceanxiety or buying merch at performanceanx.threadless.com. Now get into your fighting stance and check out Jeremy Wilms on Performance Anxiety on the Pantheon Podcast Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jak znaleźć przedszkole w Niemczech? Czy moje dziecko musi mówić po niemiecku, kiedy posyłam je do przedszkola? Co dziecko musi umieć, kiedy kończy przedszkole i idzie do szkoły? Jak załatwić przedszkole w Niemczech? W jakim wieku można zapisać dziecko do przedszkola? Gościem Tomasza Kyci jest Sonia Wilms, kierowniczka berlińskiego przedszkola St. Laurentius. KONTAKT: cosmopopolsku@rbb-online.de STRONA: www.wdr.de/k/cosmopopolsku BĄDŹ NA BIEŻĄCO: www.facebook.com/cosmopopolsku Von Thomas Kycia.

Atlanta Opera artistic director Tomer Zvulun and lead soprano Gabriella Reyes discuss their new “La Bohème” production on stage at Cobb Energy Performing Arts Centre, January 20th through 28th. Plus, multi-instrumentalist and composer Jermery Wilms takes the stage in our series, “Speaking of Music.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Atlanta, GA based multi-instrumentalist singer songwriter Jeremy Wilms (J.Wilms) brings us Neil Young and his seminal 1970 release 'After The Gold Rush'. We take a deep dive into a record that has influenced Jeremy's - and countless others - songwriting and STILL, on occasion, makes him cry. Songs featured in this episode: After The Goldrush - Linda Ronstadt; The Fighter, All The Roads, Hey My - Jeremy Wilms; Carry On, Woodstock - Crosby, Stills, Nash & Young; Rockin' In The Free World, Tell Me Why, After The Gold Rush, Only Love Can Break Your Heart, Southern Man - Neil Young; Sweet Home Alabama - Lynyrd Skynyrd; The South's Gonna Do It Again - Charlie Daniels Band; Till The Morning Comes - Neil Young; Oh Lonesome Me - Don Gibson; Oh Lonesome Me, Don't Let It Bring You Down, Birds, Birds (Demo - Neil Young & Graham Nash), Birds (Mono - Neil Young Archives Vol. 1), When You Dance I Can Really Love, I Believe In You, Cripple Creek Ferry - Neil Young; Dead Flowers - Townes Van Zandt; Yes I Know - Jeremy Wilms

Interview with J. Wilms. J. Wilms is a multi-instrumentalist and singer /songwriter. Who has a new album out called The Fighter. Jeremy “J” Wilms has had a long and varied career. He received his Bachelor of Music from Georgia State University and his Master of Music from CUNY Queens College, NYC. Jeremy's jammed with Ornette Coleman at his loft and played Broadway revues at retirement communities in New Jersey (sometimes over the same weekend!) He was briefly in Chico Hamilton's band playing guitar and played bass on Broadway in the musical Fela! During the tour for Fela! Wilms performed with Patti LaBelle and played with Fela Kuti's son Femi at venues around the world including the Shrine in Lagos. He's recorded with artists as diverse as Bebel Gilberto, Beyoncé, TV On The Radio, and many others. Wilms has been a guitarist in the orchestra for MacArthur Fellowship winner Taylor Mac's 24 Decade History Of Popular Music as well as the bassist on ABC Network's The Gong Show. He was the arranger and musical director for The Heathens and other acts based at the fabled McKittrick Hotel in Manhattan, home of “Sleep No More” immersive show. Wilms arranged strings and brass for songs on Run the Jewels' RTJ 4 and Tim Fojahn's I Dreamed a Dream. Jeremy is still busy working as a sideman in both NYC and ATL, scoring for film and other media, and teaching. Wilms also releases instrumental music as Jeremy Wilms and is the leader of the metal/prog band NOMOTO.     Jeremy's Info www.jeremywilms.com https://open.spotify.com/artist/1blyz61f1zZ726LOVfGedp?si=kDNRCKTgToKMmMaFGlQAj Q https://open.spotify.com/artist/5cKrwyPCGHf8ewXhG9RRnW?si=1saWA20uRQeaFy7LoViDZ A https://www.instagram.com/jere_wilms/ https://www.facebook.com/J.WilmsMusic/

Three “civilized” men and a “savage” are adrift on a raft with little water. The “savage,” without thirst, watches the others fight over the water. Original Air Date: July 07, 1949Host: Andrew RhynesShow: Escape Special Guests:• Joseph Kearns• Ben Wright• Barney Phillips• Jack Kruschen• Wilms Herbert Narrator:• Lawrence Dobkin Author:• John Russell Adaptation:• Irving Ravetch […]

Kiara Swope stops by WAGM Studio and talks about her son Elijah Patrick Williams who was born on June 14, 2008.Elijah was 9 when he was diagnosed with nephroblastoma ( Wilms Tumor). He had endured chemo, radiation and surgeries. Elijah fought a hard 3 years before gaining his wings on March 27, 2020 at the age of 11. Dealing with depression while still trying to pickup the pieces and raise her other three children.

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Wilms Tumor⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Oncology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://podcasters.spotify.com/pod/show/medbulletsstep1/message

On this MADM, Ava & Emma Blaser with Blaser Cancer Research Fund are sharing about their research efforts for Wilms' tumor. I hope you will listen and share. Sponsor: Bob Sykes Bar B Q BobSykes.com

In today's episode of Category Visionaries, we speak with Benjamin Wilms, CEO and Co-Founder of Steadybit, a chaos engineering platform that's raised $7.8 Million in funding, about why resilience is everything in the modern software economy, and why so many companies struggle to build it into their more complex systems. Working with a small team of dedicated engineers, Steadybit wants to move beyond chaos engineering to create holistic resilience engineering solutions and empower everybody who builds and runs software. We also speak about Benjamin's background as a software developer and what it was like transitioning to the role of CEO, the original inspiration for a resilience-focused tech platform like Steadybit, having a real passion for problem solving and sharing knowledge, and why chaos engineering is key to making sure everything runs the way it should in the real world. Topics Discussed: Benjamin's background in software development, and his history of developing resilience-first software solutions The transition from developer to CEO, and confronting the challenges of time management and decision making The central role of chaos engineering in building long-term resilience for systems operating in an unpredictable digital space Why the term ‘chaos engineering' itself has great marketing potential, and how attracting initial interest is a big part of business growth How learning from failure is such an important part of aspect of developing a business, but why that doesn't mean it's always easy

Steadybit is a Chaos and Resilience Engineering platform that helps to proactively reduce downtime and provide visibility into systems to detect issues. Your business deserves the best possible preventive action, no matter how complex your system landscape is. steady bit adds that little extra certainty to your development and testing workflow. Connect with Benjamin

Guest: Adam Hopler, an Estate Attorney from the firm Hopler, Wilms, & Hanna PLLC. Adam shares about his personal background, including his experience of practicing law in Durham for 12 years and being a father to six kids. Discussion about the intersection of family law and estate planning: how divorce and separation can impact one's estate and the importance of consultation with estate attorneys. The podcast addresses certain scenarios where it becomes essential to speak with an estate attorney, such as in cases of separations involving substantial estates or closely held businesses. Adam elaborates on how estate planning isn't just about the individual but also about those around them, who may end up dealing with the consequences of inadequate planning. Discussion on the need for life insurance and how it's meant to cover debts so that dependents don't have to. The podcast addresses the importance of revisiting estate plans periodically due to life changes and gives an example of how the pandemic has accelerated these changes for many. Adam talks about the significance of beneficiary designations and shares an anecdote from his law school days. Discussion about what happens if a person dies without a will, or 'intestate', in North Carolina, with particular emphasis on the role of a spouse and children in the division of the estate. The hosts conclude with a discussion on the importance of estate planning, even in complex family situations, such as split families, and during periods of separation before divorce is finalized. Note: For expert advice tailored to your specific circumstances, it is always recommended to consult with a certified legal professional in your area.

The availability and quality of cancer care varies in different parts of the globe. Some locations find it difficult to have proper equipment, access to medications or even trained staff on hand. In this ASCO Education podcast we look how a group of doctors are sharing their skills and experience to set up training programs to help improve outcomes for patients with cancer in Kenya. Our guests will explore the creation of a pediatric oncology fellowship program in Kenya (11:48), how a young doctor found herself interested in improving global health (14:30), and discuss lessons learned that are applicable to health care in the United States (21:07).  Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Terry Vik: Research Funding Takeda, Bristol Myers Squibb Foundation Dr. Jennifer Morgan: None Resources: Podcast: Oncology, Etc. - Dr. Miriam Mutebi on Improving Cancer Care in Africa Podcast: Oncology, Etc. – Global Cancer Policy Leader Dr. Richard Sullivan (Part 1) Podcast: Oncology, Etc. – Global Cancer Policy Leader Dr. Richard Sullivan Part 2 If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Disclosures for this podcast are listed in the podcast page. Dave Johnson: Welcome, everyone, to a special edition of Oncology, Etc., an oncology educational podcast designed to introduce our listeners to interesting people and topics in and outside the world of Oncology. Today's guest is my co-host, Dr. Pat Loehrer, who is the Joseph and Jackie Cusick Professor of Oncology and Distinguished Professor of Medicine at Indiana University, where he serves as the Director of Global Health and Health Equity. Pat is the Director Emeritus of the Indiana University Simon Comprehensive Cancer Center. Pat has many different accomplishments, and I could spend the next hour listing all of those, but I just want to point out, as many of you know, he is the founder of what formerly was known as the Hoosier Oncology Group, one of the prototypes of community-academic partnerships which have been hugely successful over the years.  He's also the founding director of the Academic Model for Providing Access to Healthcare Oncology Program, which has grown rather dramatically over the last 17 years. This includes the establishment of fellowship programs in GYN oncology, pediatric oncology, and medical oncology through the Moi University School of Medicine in Kenya. Through its partnership with the Moi Teaching and Referral Hospital, over 8000 cancer patients a year are seen, and over 120,000 women from western Kenya have been screened for breast and cervical cancer in the past five years. Pat is also the co-PI of the U-54 grant that focuses on longitudinal HPV screening of women in East Africa. He currently serves as a Senior Consultant of the NCI Cancer for Global Health.  So, Pat, welcome. We have with us today two special guests as well that I will ask Pat to introduce to you. Pat Loehrer: Dave, thanks for the very kind introduction. I'm so pleased today to have my colleagues who are working diligently with us in Kenya. The first is Terry Vik, who is Professor of Pediatrics here at Indiana University and at Riley Hospital. He's been the Director of the Fellowship Program and the Pediatric Hematology-Oncology Program and Director of the Childhood Cancer Survivor Program. He got his medical degree at Johns Hopkins and did his residency at UCLA and his fellowship at Dana-Farber. And he's been, for the last 10 to 15 years, been one of my co-partners in terms of developing our work in Kenya, focusing on the pediatric population, where he helps spearhead the first pediatric oncology fellowship in the country.  And then joining us also is Dr. Jennifer Morgan. Jenny is a new faculty member with us at Indiana University as an Assistant Professor. She, I think, has 16 state championship medals for track and field in high school. I've never met an athlete like that in the past. She ended up going to Northwestern Medical School. She spent time in Rwanda with Partners in Health, and through that, eventually got interested in oncology, where she completed her fellowship at University of North Carolina and has spent a lot of her time in Malawi doing breast cancer research. I don't know of anyone who has spent as much time at such a young age in global oncology.  Dave Johnson: So Pat, obviously, you and I have talked a lot over the years about your work in Kenya, but our listeners may not know about Eldoret. Maybe you can tell us a little bit about the history of the relationship between your institution and that in Kenya. Pat Loehrer: It's really a remarkable story. About 30 some odd years ago, Joe Mamlin and Bob Einterz, and Charlie Kelly decided they wanted to do a partnership in Global Health. And they looked around the world and looked at Nepal and looked at Mexico, and they fell upon Eldoret, which was in Western Kenya. They had the birth of a brand new medical school there, and this partnership developed. In the midst of this came the HIV/AIDS pandemic. And these gentlemen worked with their colleagues in Kenya to develop one of the most impressive programs in the world focused on population health and dealing with the AIDS pandemic. They called it the Academic Model for Prevention and Treatment of HIV/AIDS or AMPATH, and their success has been modeled in many other places. They have many different institutions from North America and Europe that have gone there to serve Western Kenya, which has a catchment area of about 25 million people.  About 15 to 20 years ago, I visited AMPATH, and what they had done with HIV/AIDS was extraordinary. But what we were seeing there in cancer was heartbreaking. It reminded us, Dave, as you remember back in the ‘60s and ‘70s with people coming in with advanced cancers of the head and neck and breast cancers that were untreated. And in addition, we saw these young kids with Burkitt's Lymphomas with huge masses out of their jaws. And seeing that and knowing what was possible, what we saw in the States and what seemed to be impossible in Kenya, spurred me on, as well as a number of other people, to get involved. And so, we have built up this program over the last 15 and 20 years, and I think it's one of the most successful models of global oncology that's in existence.  Dave Johnson: That's awesome. Terry, tell us a little bit about your involvement with the program at Moi University.  Terry Vik: Sure. So, I took an unusual path to get to Eldoret because I started off in work in signal transduction and protein kinases, then morphed into phase I studies of kinase inhibitors that was happening in the early 2000s. But by the end of the decade, Pat was beginning to establish oncology programs in Kenya. And because half the population is children and there were lots of childhood cancers, and many of them can be curable, he mildly twisted my arm to go with him to set up pediatric oncology in Kenya. And through his help and Matt Strother, who is a faculty member on the ground, establishing that, I first went in 2010 just to see how things were running and to see all the things that Pat had recognized as far as things that needed to be done to make Eldoret a center for cancer care.   And so, the last 13 years now, I've been working, going anywhere from one to four times a year to Kenya, mainly helping the Kenyans to develop their medical care system. Not so much seeing patients or taking care of patients, other than talking about best practices and how we do things in the US that can be readily translated to what's going on in Kenya. And so, we've been able to establish a database, keep track of our patients in pediatric oncology, recognize that lots of kids are not coming into care, not being diagnosed. There's a huge gap between numbers who you would expect to have childhood cancer versus the numbers actually coming to the hospital. As the only pediatric treatment center for a catchment area of 25 million, half of whom are under the age of 20, we should be seeing a lot of kids with cancer, but we are probably only seeing 10% of what we would expect.  So, myself, many of my colleagues from Indiana University, as well as colleagues from the Netherlands Princess Maxima Hospital for Pediatric Cancer, we've been partnering for these past 13 years to train Kenyans to recognize cancer, to have treatment protocols that are adapted for the capabilities in Kenya, and now finally starting to show real progress in survival for childhood cancer in Kenya, both in leukemias, lymphomas, and solid tumors, with a fair number of publications in Wilms tumor and Burkitt lymphoma and acute lymphoblastic leukemia. So, it's been really heartening, I think.  I tell people that the reason I go to Kenya studying signal transduction and protein kinase inhibitors in pediatric cancer, I can maybe save a couple of kids over a career by that kind of work. But going to Kenya to show people how to find and treat kids with leukemia, I'm literally seeing the impact of hundreds of kids who are alive today that wouldn't be alive otherwise. So, that's really been the success of pediatric oncology there. Dave Johnson: Is the spectrum of childhood cancer in Kenya reflective of what we see in the States, or are there some differences? Pat Loehrer: It really is surprisingly similar. I think the only thing that– Well, two things that are more common in Kenya because of the so-called ‘malaria belt' and the association with Burkitt Lymphoma, there's a fair number of kids with Burkitt's Lymphoma there. Although, as mosquito control and malaria control has improved, actually, the numbers of cases of Burkitt's have been dropping, and a lot of cancers were sort of hidden, not recognized as leukemia or not recognized as other lymphomas. Just because if Burkitt's is endemic, then every swelling is Burkitt's. And I think that's been shown by looking at pathology retrospectively to say a lot of what they thought was Burkitt's was maybe not necessarily Burkitt's. And then nasopharyngeal carcinoma with Epstein-Barr virus prevalence also is a little bit more common than I'm used to seeing, but otherwise, the spectrum of cancers are pretty similar. So, it's heartening to know that we've been treating childhood cancers with simple medicines, generic medicines, for 50 years in the US. And so I like to tell people, I just want to get us up to the ‘90s, maybe the 2000s in Kenya, and that will really improve the survival quite a bit. Dave Johnson: You mentioned that there were adjustments that you were making in the therapies. Could you give us some examples of what you're talking about? Terry Vik: The biggest adjustments are that the ability to give blood product support, transfusions of platelets is somewhat limited. So, for instance, our ability to treat acute myeloid leukemia, which is heavily dependent on intensive myelosuppressive chemotherapy, we're not so good at that yet because we don't have the support for blood products. Similarly, the recognition and treatment of infections in patients is somewhat limited. Yet, just the cost of doing blood cultures, getting results, we actually have the antibiotics to treat them, but figuring out that there actually is an infection, and we're just beginning to look at resistance patterns in bacteria in Kenya because I think that's an indiscriminate use of antibiotics. In Kenya, there are a lot of resistant organisms that are being identified, and so figuring out how best to manage those are the two biggest things. But now, in Eldoret, we have two linear accelerators that can give contemporary radiation therapy to kids who need it. We have pediatric surgeons who can resect large abdominal tumors. We have orthopedic surgeons and neurosurgeons to assist. All those things are in place in the last three to five years. So, really, the ability to support patients through intensive chemotherapy is still one of the last things that we're working diligently on improving. Dave Johnson: So one thing that I've read that you've done is you're involved heavily in the creation of a pediatric oncology fellowship program. If I read it correctly, it's a faculty of one; is that correct? Terry Vik: Well, now that two have just graduated, it's a faculty of three, plus some guest lecturers. So I feel quite good about that.  Dave Johnson: So tell us about that. That must have been quite the challenge. I mean, that's remarkable. Terry Vik: That goes back to one of my longtime colleagues in Kenya, Festus Njuguna, who is Kenyan. He did his medical school training at Moi University and then did pediatric residency there. They call it a registrar program there. And then he was, since 2009, 2010, he's been the primary pediatric oncologist. Although he always felt he did not have the formal training. He'd spent time in the US and in Amsterdam to get some added training for caring for kids. But it was his vision to create this fellowship program. So Jodi Skiles, one of my colleagues who had spent some time in Kenya and myself and he worked on creating the fellowship document that needs to go through the university to get approved. That finally got approved in 2019. And so the first two fellows…I was on a Fulbright Scholar Award to start that fellowship program for a year right in the middle of the pandemic, but we were able to get it started, and I was able to continue to go back and forth to Kenya quite a bit in the last two years to get through all of the training that was laid out in our curriculum. And two fellows, Festus and another long-standing colleague of mine, Gilbert Olbara, both completed the fellowship and then sat for their final exams at the end of last year and graduated in December. So it really was heartwarming for me to see these guys want to build up the workforce capacity from within Kenya, and being able to support them to do that was a good thing. Pat Loehrer: Parenthetically, Dave, we had the first Gynecology Oncology program in the country, too, led by Barry Rosen from Princess Margaret, and they have 14 graduates, and two of them now are department chairs in Kenya. Jenny's spearheading a medical oncology curriculum now so that we have that opened up this year for the first time. Dave Johnson: It's uncommon to find a junior faculty as accomplished as Jenny. Jenny, tell us a little about your background and how you got interested in global health, and your previous work before moving to IU.  Jennifer Morgan: I was an anthropology major at undergrad at Michigan, and I think I really always liked studying other cultures, understanding different points of view. And so I think part of that spirit when you study anthropology, it really sticks with you, and you become a pretty good observer of people and situations, I think, or the goal is that you become good at it. I think my interest in medicine and science, combined with that desire to learn about different cultures really fueled a lot of my interests, even from undergrad and medical school. I really felt strongly that access to health is a human right, and I wanted to work for Partners in Health when I graduated from residency. I had heard a lot about that organization and really believed in the mission around it.   And so I went to work in Butaro in Rwanda, and I really didn't have any plans to do cancer care, but then I just kind of got thrown into cancer care, and I really loved it. It was a task-shifting model that really where you use internists to deliver oncology care under the supervision of oncologists from North America. So, most of them were from Dana-Farber or a variety of different universities. And so it made me feel like this high-resource field of Oncology was feasible, even when resources and health systems are strained. Because I think a lot of people who are interested in Oncology but also kind of this field of global health or working in underserved settings really struggle to find the way that the two fit sometimes because it can feel impossible with the hyper-expensive drugs, the small PFS benefits that drive the field sometimes. And so I think, Butaro for me, and Partners in Health, and DFCI, that whole group of people and the team there, I think, really showed me that it's feasible, it's possible, and that you can cure people of cancer even in small rural settings. And so that drove me to go to fellowship, to work with Satish Gopal and UNC. And because of COVID, my time in Malawi was a bit limited, but I still went and did mainly projects focused on breast cancer care and implementation science, and they just really have a really nice group of people. And I worked with Tamiwe Tomoka, Shakinah Elmore, Matthew Painschab, really just some great people there, and I learned a lot.  And so, when I was looking for a job after fellowship, I really wanted to focus on building health systems. And to me, that was really congruent with the mission of AMPATH, which is the tripartite mission of advancing education and research and clinical care. And I knew from Pat that the fellowship program would be starting off, and I think to me, having been in Rwanda and Malawi and realizing how essential building an oncology workforce is, being a part of helping build a fellowship as part of an academic partnership was really exciting. And then also doing very necessary clinical outcomes research and trying to do trials and trying to bring access to care in many systems that are very resource constrained. So that's kind of how I ended up here.  Pat Loehrer: That's awesome. So tell us a little bit about your breast cancer work. What exactly are you doing at the moment? Jennifer Morgan: In Malawi, during my fellowship, we looked at the outcomes of women with breast cancer and really looking at late-stage presentations and the fact that in Malawi, we were only equipped with surgery, chemotherapy, and hormone therapy, but not radiation. You see a lot of stage four disease, but you also see a lot of stage three disease that you actually have trouble curing because it's so locally advanced, really bulky disease. And so that first study showed us the challenge of trying to cure patients– They may not have metastatic disease, but it can be really hard to locally even treat the disease, especially without radiation. And so that's kind of what we learned.   And then, using an implementation science framework, we were looking at what are the barriers to accessing care. And I think it was really interesting some of the things that we found. In Malawi, that has a high HIV rate, is that the stigma around cancer can be far more powerful than the stigma around HIV. And so, we are seeing a lot of women who are ostracized by their communities when they were diagnosed with cancer. And really, they had been on, many HIV-positive women, on ARVs for a long time living in their communities with no problem, and so HIV had kind of been destigmatized, but we're seeing the stigma of cancer and the idea that kids are as a death sentence was a really prominent theme that we saw in Malawi.  So some of these themes, not all of them, but some of them are very similar in Kenya, and so what I'm helping work on now is there's been this huge effort with AMPATH called the Breast and Cervical Cancer Screening Program, where around 180,000 women have been screened for breast cancer in a decentralized setting which is so important - so in counties and in communities. We're looking at who showed up to this screening and why did women only get breast cancer screening and why did some of them only get cervical, and why did some get what was intended - both. Because I think many people on the continent and then other LMICs are trying to do breast and cervical cancer co-screening to really reduce the mortality of both of those cancers. And the question is, I think: is mammography a viable screening mechanism in this setting or not? That's a real question in Kenya right now. And so we're going to be looking to do some studies around mammography use and training as well.  Dave Johnson: So, I have a question for all three of you. What lessons have you learned in your work in Kenya or Malawi that you've brought back to the States to improve care in the United States? Pat Loehrer: One is that the cost of care is ever present there. And so one of the things that we need to think about here is how can we deliver care more cheaply and more efficiently. It goes against the drug trials that are going on by industry where they want to use therapy for as long as they can and for greater times. And there are a lot of common things like access to care is a big issue there, and it's a big issue in our country. So we have used in IU some community healthcare workers in rural parts of our state as well as in the urban centers so that they can go to people's houses to deliver care.  Terry was involved with a wonderful project. It was a supplement from the NCI, which looked at barriers to care and abandonment of therapy. And just by giving patients and their families a small stipend that would cover for their travel and their food, the abandonment rate went down substantially, and they were able to improve the cure rate of Burkitt's Lymphoma. It's probably about 60% now. And so those are issues that I think we see here in our state, where people can't come to IU because of the cost of parking, that's $20 a visit. The lesson there is that we really need to get down to the patients and to their families and find out what their obstacles are.  Terry Vik: My favorite example, since I deal with kids and parents, is how striking parents are the same worldwide. They all want the best for their child. They all want anything that can be done to potentially cure them, treatment, they do anything they could. And I think the hardest thing, as Pat said, is the financial burden of that care. And the other thing that I bring back to my fellows in the US is that you don't have to do Q4-hour or Q6-hour labs to follow somebody when they start their therapy. Once a day, every 3 days, works quite well also. And just the realization that things can be done with a lot less stress in the US if you only decide to do it. Dave Johnson: Jenny, any thoughts from you on that? Jennifer Morgan: I think for me, decentralized cancer care is so important. Even being back on the oncology wards in Indiana in December, I saw a couple of really advanced patients who were really unfortunate, and they had tried to go through the system of referrals and getting to cancer care. And unfortunately, I think there are disparities in the US health system, just like in Kenya, and maybe on different scales. But cancer care that's accessible is so important, and accessible versus available, I think we a lot of time talk about therapies that may be available, but they're not accessible to patients. And that's really what we see in Kenya, what we see in rural Indiana. There are a number of grants that talk about reciprocal innovation because some of these things that we do in Kenya to minimize burden on the system are things that can be done in rural Indiana as well. And so, partnership on these issues of trying to improve decentralized care is important everywhere.  Pat Loehrer: And again, from the perspective as a medical oncologist, we see patients with late-stage diseases. We could eradicate the number one cause of cancer in Sub-Saharan Africa, cervical cancer, from the face of the earth just by doing prevention. We don't do enough in our country about prevention. The other dimension I guess I wanted to bring up as far as multidisciplinary care - when we think about that in our country, it's radiation therapy, surgery, medical oncology, but one of the lessons learned there is that the fourth pillar is policy. It's really about cancer policy and working with the government, Ministry of Health to affect better insurance cover and better care and to work with a different discipline in terms of primary care, much more strongly than we do in our country.  Dave Johnson: Are you encountering similar levels of vaccine hesitancy in Kenya as you might see in the States, or is that something that's less of an issue? Pat Loehrer: I'll let Terry and Jenny answer that. Terry Vik: I think there is some degree of vaccine hesitancy, and not so much that it's fear of the vaccine, but it's fear of the people pushing the vaccine. If it's coming from the government or if it's coming from outside drug companies or outside physician recommendations, it's less likely to be taken up. And if it's coming from within their own community or if it's their chiefs and their community leaders they respected, then I think there is less vaccine hesitancy certainly in a lot of things we do in pediatrics. So I think there is hesitancy, but it's coming from a different source than what we see in the US.   Jennifer Morgan: I would agree, and I think also COVID has changed the game on vaccine perceptions everywhere, and I don't think Kenya is spared from that either. So it may take a few years to see really what's going on with that.   Pat Loehrer: Jenny and I were at this conference, it's a Cancer Summit in Nairobi a couple of weeks ago, and we saw this little documentary there. And this notion of misinformation, as we've seen in our country, is also common over there. They were interviewing a number of men and women from Northern Kenya about prostate cancer, which is a very serious problem in Kenya. The notion was that even doing PSA screening caused infertility, and so the men and women didn't want their husbands to get screened for prostate cancer because they would become less fertile by doing that. So, again, there are lessons that we– as Jenny mentioned from the top about anthropology, I think we're all connected, we all have different ways of viewing communications in health, but I do think that we can learn from each other substantially. Dave Johnson: I mean, it's remarkable work. How is it funded?  Pat Loehrer: Well, I've been fortunate to be able to work with some friends who are philanthropists. We've had strong support as we've told our story with various different foundations. And we've been very grateful to Pfizer, who are very helpful to us in the early stages of this - Lilly Foundation, Takeda, Celgene. And I think as we basically share our vision of what we're trying to accomplish, we've been very humbled by the support that we have gotten for us. The U54 helps support some of the research. We have D43 we're doing through Brown University. So we plan to increase our research funding as best as we can. But this is active generosity by some wonderful people. We have a $5.5 million cancer and chronic care building in which a large sum of it came from Indiana University and the Department of Radiation Oncology. Dr. Peter Johnstone helped lead that. There was a Lilly heir that gave us quite a bit of money. An Indian Kenyan named Chandaria also donated money. So it's a matter of presenting the vision and then looking for people that want to invest in this vision.  Well, I just want to say, from my perspective, I am more of a cheerleader than on the field. But Terry, I know you spent a tremendous amount of time on the ground in Kenya, and Jenny, you're living there. I just wanted to say publicly that you guys are my heroes. Dave Johnson: Yeah. I think all of our listeners will be impressed by what they heard today, and we very much appreciate you both taking time to chat with us.  So at this point, I want to thank our listeners of Oncology, Etc., an ASCO Educational Podcast. This is where we'll talk about oncology medicine and beyond. So if you have an idea for a topic or a guest you'd like us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, please visit education.asco.org.  Pat, before we go, I have an important question to ask you. Pat Loehrer: I can't wait. Dave Johnson: Do you know how snails travel by ship?  Pat Loehrer: As cargo! Dave Johnson: Awesome. You got it. All right. Well, Terry and Jenny, thank you so much for taking time to chat with us. It's been great. I'm very impressed with the work you guys are doing. Really appreciate your efforts. Terry Vik: Great. Thank you. Jennifer Morgan: Thank you. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Ava Blaser was 3 years old when she was diagnosed with Stage 5 Bilateral Wilms Tumor in 2011. Her sister Emma, who is 6 years older than Ava will talk about her sister's ultimately successful fight against this form of Pediatric Cancer in which Ava relapsed when she was 10, but has now been cancer free for more than 4 years.Emma took it upon herself at 16 years old when Ava relapsed to become a passionate and compassionate advocate for the cause of Wilms Tumor and Pediatric Cancer as Ava's sibling. Emma is now a spokeswoman for the Arms Wide Open Childhood Cancer Foundation and has spread her message to many siblings who have gone through what Emma and Ava have gone through together. 

Have you heard of Wilms' tumor? If not, Emma Blaser with Blaser Cancer Research Fund is going to share some information about it. I hope you will listen and share. March is Kidney Disease/Cancer Awareness Month! Sponsor: Bob Sykes Bar B Q BobSykes.com

Hannah Adams began her Pediatric Cancer advocacy work when she was just 8 years old, becoming the youngest captain in Florida for the Relay For Life event that is sponsored by the American Cancer Society. That was followed up by her being chosen at the age of 12 to be the National Youth Ambassador for Hyundai Motors for their Hope on Wheels Program. Hannah will talk about her incredible advocacy work for Pediatric Cancer, which was preceded by her own battle with a Wilms Tumor when she was 5 1/2 years old. Hannah is now a sophomore at the University of Alabama, is the reigning Miss Birmingham, and has previously been voted the outstanding Teen in Florida and the outstanding National Teen by the Miss America organization. 

Did you know why failures are your friend when it comes to testing? In this episode, Benjamin Wilms, co-founder of Steadybit, shares his views on resilience testing. Discover the difference between reliability, chaos, and resilience engineering, how resilience is a team sport, testing best practices, and how the Steadybit platform can help. Listen up!

FITTER RADIO COFFEE CLUB MEMBER NIC MOON: (00:08:06) Nic won the free race entry to the IM70.3 in Taupo. We find out how her race went. HOT PROPERTY INTERVIEW: LOTTE WILMS (00:21:48) We chat to Dutch born (Australian based) triathlete Lotte Wilms about her history in the sport and her transition to long distance triathlon. LINKS: More about MitoQ at https://www.mitoq.com/ Training Peaks discount at https://www.fitter.co.nz/about-radio INFINIT Nutrition discount at https://www.fitter.co.nz/about-radio More about Infinit Nutrition Australia at https://www.infinitnutrition.com.au/ More about the Floe Bottle at https://www.floebottle.com/ IRONMAN New Zealand at https://www.ironman.com/im-new-zealand Follow Lotte Wilms on Instagram at https://www.instagram.com/lotte_wilms/ More about Scott Tindal and Fuel.in at https://www.fuelin.com/   CONTACT US: Learn more about us at https://www.fitter.co.nz        Mikki Williden can be found at https://mikkiwilliden.com/

We're featuring Journal of pediatric surgery articles earlier in the week to bring you some of the latest news! This week we're discussing two articles from the September 2022 issue, with the editor Dr. Whit Holcomb and Authors Drs Andrew Murphy and Hafeez Abdelhafeez Hosts: Em Tombash and Cecilia Gigena  Articles:  "Management of intravascular thrombus in cases of bilateral Wilms tumor or horseshoe kidney"  Pattamon Sutthatarn a , b , Oswaldo Gomez Quevedo a , Joesph Gleason a , c , Andrew M. Davidoffa , d , Andrew J. Murphya , d , ∗ DOI: https://www.jpedsurg.org/article/S0022-3468(21)00534-0/fulltext "Indocyanine green–guided nephron-sparing surgery for pediatric renal tumors" Abdelhafeez H. Abdelhafeez a , b , ∗, Andrew J. Murphy a , b , Rachel Brennan c , Teresa C. Santiago d , Zhaohua Lu e , Matthew J. Krasin f , John J. Bissler g , Joseph M. Gleason a , h , Andrew M. Davidoff DOI: https://www.jpedsurg.org/article/S0022-3468(21)00566-2/fulltext

We're featuring Journal of Pediatric Surgery articles earlier in the week to bring you some of the latest news! This week we're discussing two articles from the August 2022 issue, with editor Dr. Pablo Laje and authors Drs. Reza Shojaeian and Mehran Hiradfar. Hosts: Ellen Encisco, Cecilia Gigena, Em Tombash Articles: "Sentinel lymph node biopsy in pediatric Wilms tumor" Ramin Sadeghi, Reza Shojaeian, Mehran Hiradfar, Ahmad Mohammadipour, Ali Azadmand, Mahdi Parvizi Mashhadi DOI:https://doi.org/10.1016/j.jpedsurg.2021.12.037 Extracorporeal Membrane Oxygenation (ECMO) and its complications in newborns with congenital diaphragmatic hernia" Latoya A. Stewart, Rafael Klein-Cloud, Claire Gerall, Lynn L. Simpson, Wendy K. Chung, Vincent P. Duron DOI:https://doi.org/10.1016/j.jpedsurg.2021.12.028

Benjamin Wilms started his career in 1999 as a developer. In the little free time he has, he does mountain biking, spends time with his family, and visits the ocean a few hours away. For mountain biking, he finds that it helps him to keep life balanced away from a screen, and the ocean - well... he just likes to watch his kids play on the beach.Seven years go, Ben started getting into the topic of Chao's engineering, while working as a consultant. As he learned about the tools on the market, he realized that to get the tool in production, it required him to understand all the codebase test coverage, without knowledge of SRE. He released on open source project of his own creation, and his approach got picked up by big name enterprises.This is the creation story of Steadybit.SponsorsAirbyteDopplerHost.ioIPInfomablLinksWebsite: https://steadybit.com/LinkedIn: https://www.linkedin.com/in/benjamin-wilms/Support this podcast at — https://redcircle.com/code-story/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

When Kathleen Casey's son Barrett (Bear) was diagnosed with Wilms Tumor in the late 1980's, she was told that this kidney cancer was highly curable and the expectation at that time was that her son would recover and be able to lead a good life which many children diagnosed with this cancer are able to do.  Unfortunately, things turned south rather quickly and after a 5 1/2 year battle , Bear passed away in January of 1993.That same year, Kathleen started the Bear Necessities Pediatric Cancer Foundation in honor and memory of her son. The 2 Missions of this Foundation are 1) Research and 2) helping Children with Pediatric Cancer rediscover their childhoods. Kathleen's Foundation has persevered for almost 30 years and has become part of the fabric of the city of Chicago. 

Like everything else, power is a two-sided coin. It can be coercive and oppressive, but it can also be empowering and nurturing. And according to ancient Chinese texts, true authority is based on ethical inspiration rather than coercion. As physicians, we are in a position of authority—not by claiming the power, but by earning it from competence in our trade.  Our position of influence demands that we use our expertise and influence to help others—and this starts from our own mastery of yangsheng. People will willingly follow someone with virtue; de. "Knowing others is intelligence; knowing yourself is true wisdom. Mastering others is strength, mastering yourself is true power." —Lao Tzu In this conversation with Sabine Wilms, we explore the complex dynamics of power and the idea of a virtuous hierarchy borne out of the authority of competence. We also bat around the inadequacies of translations and the limitations of language. And as a storyteller at heart, Sabine weighs up the concept of yangsheng using some popular Chinese teaching tales. Listen into this discussion on mastering the art of yangsheng (養生) as a practitioner, the role of virtue de (德 ), medical ethics, the dynamics of power, and stepping into your ming (命).

Like everything else, power is a two-sided coin. It can be coercive and oppressive, but it can also be empowering and nurturing. And according to ancient Chinese texts, true authority is based on ethical inspiration rather than coercion. As physicians, we are in a position of authority—not by claiming the power, but by earning it from competence in our trade. Our position of influence demands that we use our expertise and influence to help others—and this starts from our own mastery of yangsheng. People will willingly follow someone with virtue; de. "Knowing others is intelligence; knowing yourself is true wisdom. Mastering others is strength, mastering yourself is true power." —Lao Tzu In this conversation with Sabine Wilms, we explore the complex dynamics of power and the idea of a virtuous hierarchy borne out of the authority of competence. We also bat around the inadequacies of translations and the limitations of language. And as a storyteller at heart, Sabine weighs up the concept of yangsheng using some popular Chinese teaching tales. Listen into this discussion on mastering the art of yangsheng (養生) as a practitioner, the role of virtue de (德 ), medical ethics, the dynamics of power, and stepping into your ming命).